Greenwich LifeSciences, Inc. (GLSI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 9, 2022, reports the results of the Annual Meeting of Stockholders held on that date. Greenwich LifeSciences, Inc., a Delaware corporation, is an emerging growth company with its principal executive offices in Stafford, Texas. The filing addresses the election of directors and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes and Voting Results
A total of 9,755,196 shares of common stock were represented at the meeting, constituting a quorum. The following matters were submitted to a vote:
- Proposal 1: Election of Directors All five nominees were elected to serve until the 2023 Annual Meeting. There were zero votes "Against" any nominee.
- David McWilliams: 8,452,115 For; 484,781 Abstain; 818,300 Broker Non-Vote.
- Snehal S. Patel: 8,567,603 For; 369,293 Abstain; 818,300 Broker Non-Vote.
- Eric Rothe: 8,526,477 For; 410,419 Abstain; 818,300 Broker Non-Vote.
- F. Joseph Daugherty, M.D.: 8,532,215 For; 404,681 Abstain; 818,300 Broker Non-Vote.
- Kenneth Hallock: 8,561,615 For; 375,281 Abstain; 818,300 Broker Non-Vote.
- Proposal 2: Ratification of Auditors The appointment of Malone Bailey, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2022, was ratified.
- For: 9,733,708
- Against: 15,043
- Abstain: 6,444
- Broker Non-Vote: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following the unanimous election of the five nominees.
- Confirm the engagement of Malone Bailey, LLP as the independent auditor for the fiscal year ending December 31, 2022.
- Note the significant number of broker non-votes (818,300) regarding the director elections, indicating shares held by brokers that were not voted on these matters.
- Review the Definitive Proxy Statement filed on October 19, 2022, for detailed background on the nominees and auditor selection.